As of 2024-12-12, the Relative Valuation of Twist Bioscience Corp (TWST) is (81.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.86 USD, the upside of Twist Bioscience Corp based on Relative Valuation is -267.7%.
The range of the Relative Valuation is (77.43) - (86.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 29.1x | 23.3x |
| Forward P/E multiples | 21.1x - 24.5x | 23.3x |
| Fair Price | (77.43) - (86.15) | (81.93) |
| Upside | -258.5% - -276.3% | -267.7% |
| Date | P/E |
| 2024-11-29 | -13.99 |
| 2024-11-27 | -13.74 |
| 2024-11-26 | -13.18 |
| 2024-11-25 | -13.20 |
| 2024-11-22 | -12.01 |
| 2024-11-21 | -11.85 |
| 2024-11-20 | -11.69 |
| 2024-11-19 | -11.75 |
| 2024-11-18 | -11.78 |
| 2024-11-15 | -10.49 |
| 2024-11-14 | -11.08 |
| 2024-11-13 | -12.08 |
| 2024-11-12 | -12.87 |
| 2024-11-11 | -13.45 |
| 2024-11-08 | -12.91 |
| 2024-11-07 | -12.95 |
| 2024-11-06 | -12.92 |
| 2024-11-05 | -12.27 |
| 2024-11-04 | -11.96 |
| 2024-11-01 | -11.82 |
| 2024-10-31 | -11.48 |
| 2024-10-30 | -12.28 |
| 2024-10-29 | -12.13 |
| 2024-10-28 | -12.09 |
| 2024-10-25 | -11.55 |
| 2024-10-24 | -11.44 |
| 2024-10-23 | -11.69 |
| 2024-10-22 | -12.46 |
| 2024-10-21 | -12.90 |
| 2024-10-18 | -13.35 |
| 2024-10-17 | -12.95 |
| 2024-10-16 | -12.82 |
| 2024-10-15 | -13.17 |
| 2024-10-14 | -13.26 |
| 2024-10-11 | -12.65 |
| 2024-10-10 | -11.84 |
| 2024-10-09 | -11.79 |
| 2024-10-08 | -12.10 |
| 2024-10-07 | -11.99 |
| 2024-10-04 | -12.33 |
| 2024-10-03 | -12.17 |
| 2024-10-02 | -12.31 |
| 2024-10-01 | -12.34 |
| 2024-09-30 | -12.85 |
| 2024-09-27 | -13.19 |
| 2024-09-26 | -13.39 |
| 2024-09-25 | -12.99 |
| 2024-09-24 | -13.21 |
| 2024-09-23 | -12.88 |
| 2024-09-20 | -13.21 |